反応式
[CH2:1]1[C:6](=[O:7])[N:5]([O:8][C:9]([CH2:11][CH2:12][S:13][S:14][C:15]2[N:20]=[CH:19][CH:18]=[CH:17][CH:16]=2)=[O:10])[C:3](=[O:4])[CH2:2]1.[CH2:21]([SH:28])[C@@H:22]([OH:27])[C@H:23]([OH:26])[CH2:24][SH:25].C1C(CN2C(=O)C=CC2=O)CCC(C(ON2C(=O)CCC2=O)=O)C1>>[CH2:1]1[C:6](=[O:7])[N:5]([O:8][C:9]([CH2:11][CH2:12][S:13][S:14][C:15]2[N:20]=[CH:19][CH:18]=[CH:17][CH:16]=2)=[O:10])[C:3](=[O:4])[CH2:2]1.[CH2:21]([SH:28])[C@@H:22]([OH:27])[C@H:23]([OH:26])[CH2:24][SH:25]参加物
4
実験手順
SPDP-modified/DTT-reduced streptavidin is mixed with SMCC-modified BLA (equimolar ratio) and allowed to react for 1-2 hrs RT (or overnight at 4 degrees). The streptavidin-BLA conjugate product is purified by gel filtration over P-60 resin.
後処理
- customto react for 1-2 hrs RT (or overnight at 4 degrees)
- filtrationThe streptavidin-BLA conjugate product is purified by gel filtration over P-60 resin
出典と根拠
- ORDレコード
- ord-140178af5867432dbe2b7afad34eb7ab
- 出典データセット
- uspto-grants-2012_11
- 特許番号
- US08318450B2
関連ノート
読み込み中…